ASG co-founders Marcie Black and Bill Rever
Advanced Silicon Group (ASG) is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Marcie Black told us the story behind their innovation and shared their vision for its future.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
ASG is enabling drug developers to measure the concentration of biomarkers in patients’ blood, giving an early indicator in clinical trials. Continue reading
Clockwise from top left: Christopher Locher, CEO/Co-Founder; Mark Duffy, CFO/COO; Kien Nguyen, Senior Director, Microbiology; David Putnam, Co-Founder; Matthew DeLisa, Co-Founder; Ly Phan, SVP, Portfolio Management & Preclinical Development
Meet Versatope, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. SVP Ly Phan described their innovation and shared the story behind its inspiration and development.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
An immuno-therapeutic and vaccine delivery platform made from probiotic exosomes (extracellular vesicles)—designed by nature and customized by Versatope to deliver immunity. Continue reading
Andy Kozminski and Michael Moore of MedKairos
MedKairos is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Michael Moore explained their innovation and the story behind its inspiration and development.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
One out of five biopsies fails to return a diagnosis. Our technology intervenes during the procedure, so patients will only undergo the procedure once. Continue reading
Geeta Singh of MAG Optics
MAG Optics is one of 20 finalists in the 7th annual M2D2 $200K Challenge. Geeta Singh, Co-founder and Chief Business Officer, shares the story of their innovation.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
MAG Optics is pioneering an intra-corneal implant, MAGarcs, that is the first patient-centric corneal shape-changing platform to address keratoconus, a rare degenerative disease characterized by a cone-shaped cornea. Continue reading
The panel discussion will focus on innovation in spine surgery to improve clinical outcomes. Considering the complex spinal pathology, spine surgeons leverage different technologies and techniques to achieve a safe and efficacious clinical outcome. Researchers and clinicians with a multi-disciplinary background will share their scientific data with all spine specialists. Continue reading
Dr. Lindsey Lozeau and Todd E. Alexander of AMProtection
Introducing AMProtection, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Todd Alexander shared the story of their innovation and its development so far.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
AMProtection provides platform antimicrobial coatings to prevent medical device-associated infections without promoting bacterial resistance. Continue reading
Clockwise from top left: Stephen Hourigan, CEO/Co-Founder; John Ward, President/Co-Founder; Matthew Ward, CSO/Co-Founder; Shreyas Sen, CTO/Co-Founder
Meet Drug Free Therapeutix, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder and CSO Matthew Ward took us inside the development of their innovation.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
DFTx empowers next-generation bioelectronics for pain and other conditions through machine learning and human body communication technology. Continue reading
Huanchen Li of 3D Tumor Targeting
3D Tumor Targeting is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder Huanchen Li described his innovation and shared the story behind it.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
With external magnets, we manipulate in vivo diamagnetic nanoparticles in a 3D manner into tumors, then heat the nanoparticles to destroy the tumors. Continue reading
Chris Lyons of Sleep Systems
Sleep Systems is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder and CTO Chris Lyons told us about how their innovation came about and the company’s future vision.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
Sleep Systems has developed a new methodology and a non-intrusive in-the-ear device to treat obstructive sleep apnea (OSA). Continue reading
Clockwise from top left: Michael Wing, Co-Founder, President, and COO; Karin Gregory, Co-Founder, Legal & Regulatory; James Niemi, CTO; Heather Keith, Sales & Marketing
Introducing Accelera, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. We spoke with co-founder, president, and COO Michael Wing who shared the story of their innovation.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
Accelera’s first wearable technology product is a soft personal ankle wrap embedded with patented Stochastic Resonance Stimulation (SRS) technology. It is adjustable to the individual to create a safe-to-use, low-level stimulation that restores the body’s natural level of sensitivity, leading to improved proprioception, balance, postural stability, and gait. Continue reading